Showing results (61-70 of 135) with videos related to
Sort By:
Pageof 14
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancerChristelle Clément-Duchêne, Yelena Krupitskaya, Kristen Ganjoo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancerMatthew D Galsky, Eric J Small, William K Oh, et al.Journal of Thoracic Disease|March 31, 2018
A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapyMatthew A Gubens, Jody C Chuang, Wallace Akerley, et al.Journal of the National Cancer Institute|March 27, 2019
Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of ImmunotherapyQuynh Thu Le, A Dimitrios Colevas, Brian O'Sullivan, et al.Investigational New Drugs|February 15, 2012
Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumorsPamela L Kunz, Aiwu R He, A Dimitrios Colevas, et al.International Journal of Radiation Oncology, Biology, Physics|January 25, 2012
Validation that metabolic tumor volume predicts outcome in head-and-neck cancerChad Tang, James D Murphy, Brian Khong, et al.Head & Neck|September 18, 2010
Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynxMegan E Daly, Quynh-Thu Le, Anshu K Jain, et al.Head & Neck|January 29, 2026
T1 Microscopic Oropharyngeal Carcinoma: Revealing the Unknown Primary Through Diagnostic TORSF Christopher Holsinger, Nikita Bedi, Michael C Topf, et al.Cancer|September 19, 2002
A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neckRoy B Tishler, Charles M Norris, A Dimitrios Colevas, et al.The Lancet. Oncology|December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialNancy Y Lee, Qiang Zhang, David G Pfister, et al.Pageof 14